Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome

Enrolling by invitation

Conditions studied: Prader-Willi Syndrome

In brief

Prospective observational study developed to generate more evidence of the safety profile, clinical characteristics and outcomes of patients with PWS treated with VYKAT XR.

Key facts

Study ID
NCT07450664
Run by
Soleno Therapeutics, Inc.
People needed
200
Starts
2025-11-26
Expected to finish
2028-03-02
Last updated by the study team
2026-05-19

Who can join

Age: 4 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.